Article
Quisinostat treatment improves histone acetylation and developmental competence of porcine somatic cell nuclear transfer embryos
22 Feb 2017
Abstract excerpt
Abnormal epigenetic modifications are considered a main contributing factor to low cloning efficiency. In the present study, we explored the effects of quisinostat, a novel histone deacetylase inhibitor, on blastocyst formation rate in porcine somatic-cell nuclear transfer (SCNT) embryos, on acetylation of histone H3 lysine 9 (AcH3K9), and on expression of POU5F1 protein and apoptosis-related genes BAX and BCL2....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
